Ori Biotech Bags €88M Investment to Automate Cell Therapy Manufacture

The UK company Ori Biotech has raised €88M ($100M) in Series B cash to ease the cell therapy manufacturing bottleneck using automation and standardized data collection.

The round was 40% oversubscribed and led by the US investment firm Novalis LifeSciences. The Chinese investor Puhua…